Anticoagulation Agents: Clinical Trials

6 trials of Anticoagulation Agents, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown, 1 active not recruiting, 1 completed, 1 not yet recruiting. 2 Not applicable, 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable2Active not recruiting 1, Unknown 1
Phase 31Not yet recruiting 1
Phase 41Recruiting 1

Follow Anticoagulation Agents: new trials by email Literature Review of Anticoagulation Agents trials Research Report on Anticoagulation Agents

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Randomized Trial of Anticoagulation Plus Batroxobin for Acute Cerebral Venous Thrombosis
batroxobin, Anticoagulation Agents - Cerebral Venous Thrombosis
Phase 4RecruitingXuanwu Hospital, Beijing722026-01-302026-01-20
Safety and Efficacy of Apixaban Versus Warfarin in Peritoneal Dialysis Patients With Non Valvular Atrial Fibrillation: a Prospective, Randomised, Open-label, Blinded End-point Trial (APIDP2)
Anticoagulation Agents - Atrial Fibrillation, Peritoneal Dialysis Complication
Phase 3Not yet recruitingUniversity Hospital, Caen1782024-10-302024-08-09
The PEERLESS II Study
FlowTriever System, Anticoagulation Agents - Pulmonary Embolism
Not applicableActive not recruitingInari Medical12002023-11-172026-10-08
Early Versus Late Initiation of Anticoagulation in Mild-to-moderate AIS Patients With NVAF
Anticoagulation Agents - Acute Ischemic Stroke, Atrial Fibrillation
Not applicableUnknownSecond Affiliated Hospital, Zhejiang University, School of Medicine23512023-09-152024-03-18
Anticoagulation in Gastroesophageal Varices and JAK2 Mutation
Anticoagulation Agents - Gastroesophageal Varices, JAK2 Mutation
UnknownShanghai Zhongshan Hospital402020-10-012020-08-27
FlowTriever All-Comer Registry for Patient Safety and Hemodynamics
FlowTriever System, Anticoagulation Agents - PE - Pulmonary Embolism, PE - Pulmonary Thromboembolism
CompletedInari Medical12002018-12-152025-10-01

Conditions studied

Atrial Fibrillation (2)  ·  Pulmonary Embolism (2)  ·  Hypertension, Portal (1)  ·  Intracranial Thrombosis (1)  ·  Ischemic Stroke (1)  ·  Myeloproliferative Disorders (1)  ·  Thromboembolism (1)

Sponsors

Inari Medical (2)  ·  Second Affiliated Hospital, Zhejiang University, School of Medicine (1)  ·  Shanghai Zhongshan Hospital (1)  ·  University Hospital, Caen (1)  ·  Xuanwu Hospital, Beijing (1)

Countries

Belgium (2)  ·  China (2)  ·  France (2)  ·  Germany (2)  ·  Spain (2)  ·  Switzerland (2)  ·  United States (2)  ·  Austria (1)  ·  Canada (1)  ·  Denmark (1)  ·  Netherlands (1)  ·  United Kingdom (1)

Top investigators

Bernhard Gebauer, MD (1)  ·  Catalin Toma, MD (1)  ·  Felix Mahfoud, MD (1)  ·  Frances Mae West, MD (1)  ·  Jay Giri, MD (1)

Results publications

PMID 28543980, PMID 39306346

NIH funding

2023 (1)